T-knife Therapeutics Appoints Christoph Broja to its Board of Directors
SAN FRANCISCO and BERLIN, July 01, 2025 (GLOBE NEWSWIRE) — T-knife Therapeutics, Inc., a biopharmaceutical company developing T cell receptor (TCR) engineered T cell therapies (TCR-T) to fight cancer, today announced the appointment of Christoph Broja, a Partner at EQT Life Sciences, to its Board of Directors. “We are pleased to welcome Christoph to our […]